Tourangeau Greg
Fulcrum Therapeutics, Inc. · Principal Accounting Officer
Tourangeau Greg is listed in filings as Principal Accounting Officer at Fulcrum Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Fulcrum Therapeutics, Inc. (FULC). The current snapshot covers public activity from Jan 28, 2025 to Feb 4, 2026. Reported amounts are shown as $611.0K to $316.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||